Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid

Lancet

Volumn 348, Issue 9031, 1996, Pages 846-849

  Zerr, Inga ^a   Bodemer, Monika ^a   Otto, Markus ^a   Poser, Sigrid ^a   Windl, Otto ^b   Kretzschmar, Hans A ^b   Gefeller, Olaf ^c   Weber, Thomas ^d  

^a Neurologische Klinik und Poliklinik   (Germany)

^b Inst fur Neuropathologie der U   (Germany)

^c Abt Med Stat der G   (Germany)

^d Marienkrankenhaus Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; ELECTROENCEPHALOGRAM; FEMALE; GEL ELECTROPHORESIS; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RELATIVE;

EID: 0030604908     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08077-4     Document Type: Article

References (27)

1. Chazot G, Broussolle E, Lapras CI, Blättler T, Aguzzi A, Kopp N New variant of Creutzfeldt-Jakob disease in a 26-year-old french man. Lancet. 347:1996;1181.
2. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-25.
3. Brown P, Gibbs CJJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.
4. Hayashi R, Hanyu N, Kuwabara T, Moriyama S. Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease. Acta Neurol Scand 1992; 85: 161-65.
5. Kovanen J, Erkinjuntti T, Iivanainen M, et al. Cerebral MR and CT imaging in Creutzfeldt-Jakob disease. J Comput Assist Tomogr 1985; 9: 125-28.
6. Esmonde TF, Will RG. Magnetic resonance imaging in Creutzfeldt-Jakob disease. Ann Neurol 1992; 31: 230-31.
7. Finkenstaedt M, Szudra A, Zerr I, et al. Magnetic resonance imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199: 793-98.
8. Tartaro A, Fulgente T, Delli-Pizzi C, Bonomo L, Bocola V, Onofri M. MRI alterations as an early finding in Creutzfeldt-Jakob disease. Eur J Radiol 1993; 17: 155-58.
9. Yamamoto K, Morimatsu M Increased signal in basal ganglia and white matter on magnetic resonance imaging in Creutzfeldt-Jakob disease. Ann Neurol. 32:1992;114.
10. Harrington MG, Merrill CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986; 315: 279-83.
11. Alperovitch A, Brown P, Weber T, Pocchiari M, Hofman A, Will RG The incidence of Creutzfeldt-Jakob disease in Europe in 1993. Lancet. 334:1994;918.
12. Masters CL, Harris JO, Gajdusek DC, Gibbs CJJ, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
13. Kretzschmar HA, Ironside J, DeArmond S, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: (in press).
14. Budka H, Aguzzi A, Brown P, et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5 (3): 319-22.
15. Zerr I, Bodemer M, Räcker S, et al. Cerebospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345: 1609-10.
16. Perry RT, Go RC, Harrell LE, Acton RT SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease family. Am J Med Genet. 60:1995;12-18.
17. Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996; 98: 259-64.
18. Blyth CR, Still HA. Binominal confidence intervals. J Am Statist Assoc 1983; 78: 108-16.
19. Levy SR, Chiappa KH, Burke CJ, Young RR Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol. 3:1986;1-21.
20. Masullo C, Pocchiari M, Neri G, et al. A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986). Eur J Epidemiol 1988; 4: 482-87.
21. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-65.
22. Jimi T, Wakayama Y, Shibuya Set al. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta. 211:1992;37-46.
23. Wakayama Y, Shibuya S, Kawase J, Sagawa F, Hashizume Y High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease. Klin Wochenschr. 65:1987;798-801.
24. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuron specific enolase and S-100 protein levels in CSF of patients with various neurological diseases. J Neurol Sci 1983; 60: 443-51.
25. Blisard KS, Davis LE, Harrington MG, Lovell JK, Kornfeld M, Berger ML Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci. 99:1990;75-81.
26. Hsich G, Kenny K, Gibbs CJJ, Lee KH, Harrington MG. 14-3-3 protein: a cerebrospinal fluid marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-30.
27. Lee KH, Harrington MG Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid diagnosis. Lancet. 348:1996;887.